Upcoming Investor Engagements for Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical's Upcoming Investor Conferences
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a dedicated biopharmaceutical company focused on developing and commercializing new therapies for serious rare and ultrarare genetic diseases, is excited to announce its participation in three notable investor conferences.
Details of the Conferences
These conferences represent significant opportunities for Ultragenyx to engage with investors and share insights about their innovative therapies aimed at treating critical health conditions.
45th Annual Cowen Healthcare Conference
On March 3, 2025, Ultragenyx will take part in the prestigious Cowen Healthcare Conference held in Boston. Eric Crombez, M.D., the Chief Medical Officer of Ultragenyx, is set to participate in a fireside chat and will also be available for one-on-one meetings with interested investors.
Barclays 27th Annual Global Healthcare Conference
Following the Cowen event, on March 11, 2025, Eric Crombez will again represent Ultragenyx at the Barclays Global Healthcare Conference in Miami. This event is another chance for the company to showcase its commitment to fighting rare diseases.
Leerink Partners Global Biopharma Conference
The very next day, on March 12, 2025, Ultragenyx will host a fireside chat at the Leerink Partners Global Biopharma Conference, also in Miami. These conferences are important moments for Ultragenyx to present their strategies to investors and industry stakeholders.
Engaging with Investors
Ultragenyx encourages all investors to tune in to the live and archived webcasts of these engaging discussions, which will be accessible from their official website.
About Ultragenyx Pharmaceutical
Ultragenyx is passionately dedicated to delivering novel therapies to patients suffering from serious and rare genetic conditions. With a robust portfolio of approved treatments and promising candidates, they aim to address diseases marked by high unmet medical needs and a clear biological rationale for therapy, supporting those who often lack existing treatment options.
Under the guidance of a seasoned management team specializing in rare disease drug development, Ultragenyx operates with the philosophy of efficient and effective drug development, emphasizing the urgency needed to bring safe and effective therapies to patients.
Company Contact Information
For more detailed information on Ultragenyx, please visit their official website at www.ultragenyx.com.
For inquiries, the Ultragenyx Investor Relations contact is:
Joshua Higa
ir@ultragenyx.com
Media Contact:
Carolyn Wang
media@ultragenyx.com
Frequently Asked Questions
What is Ultragenyx Pharmaceutical Inc. known for?
Ultragenyx is known for developing therapies for serious rare and ultrarare genetic diseases, focusing on providing treatment options where they are often lacking.
When will Ultragenyx participate in the investor conferences?
Ultragenyx will participate in key investor conferences on March 3, 11, and 12, 2025.
Who will represent Ultragenyx at the conferences?
Eric Crombez, M.D., the Chief Medical Officer, will represent Ultragenyx at all three conferences, engaging with investors through fireside chats and meetings.
How can I access the live webcasts of the conferences?
The live and archived webcasts will be accessible on Ultragenyx's official website during the events.
Where can I find more information about Ultragenyx?
You can find more information about Ultragenyx and their commitment to rare disease therapies by visiting their website at www.ultragenyx.com.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.